XML 29 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2013
Fair Value Measurements  
Schedule of assets measured at fair value on a recurring basis

We break down the inputs used to measure fair value for these assets at March 31, 2013 and December 31, 2012 as follows (in thousands):

 

 

 

At March 31,
2013

 

Quoted Prices in
Active Markets
(Level 1)

 

Significant Other
Observable
Inputs
(Level 2)

 

Significant
Unobservable
Inputs
(Level 3)

 

Cash equivalents (1)

 

$

96,072

 

$

91,072

 

$

5,000

 

$

 

Corporate debt securities (2)

 

205,098

 

 

205,098

 

 

Debt securities issued by U.S. government agencies (2)

 

24,939

 

 

24,939

 

 

Debt securities issued by the U.S. Treasury (2)

 

13,424

 

13,424

 

 

 

Debt securities issued by states of the United States and political subdivisions of the states (2)

 

20,800

 

 

20,800

 

 

Investment in Regulus Therapeutics Inc.

 

44,863

 

 

 

44,863

 

Equity securities (3)

 

2,619

 

2,619

 

 

 

Total

 

$

407,815

 

$

107,115

 

$

255,837

 

$

44,863

 

 

 

 

At December 31,
2012

 

Quoted Prices in
Active Markets
(Level 1)

 

Significant Other
Observable
Inputs
(Level 2)

 

Significant
Unobservable
Inputs
(Level 3)

 

Cash equivalents (1)

 

$

105,496

 

$

101,496

 

$

4,000

 

$

 

Corporate debt securities (2)

 

193,507

 

 

193,507

 

 

Debt securities issued by U.S. government agencies (2)

 

18,108

 

 

18,108

 

 

Debt securities issued by the U.S. Treasury (2)

 

13,452

 

13,452

 

 

 

Debt securities issued by states of the United States and political subdivisions of the states (2)

 

24,897

 

 

24,897

 

 

Investment in Regulus Therapeutics Inc.

 

33,622

 

 

 

33,622

 

Equity securities (3)

 

4,874

 

4,146

 

 

728

 

Total

 

$

393,956

 

$

119,094

 

$

240,512

 

$

34,350

 

 

(1)         Included in cash and cash equivalents on our consolidated balance sheet.

 

(2)         Included in short-term investments on our consolidated balance sheet.

 

(3)         Included in other current assets on our consolidated balance sheet.

 

Summary of investments measured at fair value on a recurring basis using significant unobservable inputs (Level 3)

The following is a summary of our investments measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended March 31, 2013 (in thousands):

 

 

 

Investments

Valued Using

Level 3 Inputs

 

Balance at December 31, 2012

 

$

34,350

 

Total gains and losses:

 

 

 

Included in gain on investments

 

(1,163

)

Included in accumulated other comprehensive income (loss)

 

11,716

 

Cost basis of shares sold

 

(40

)

Balance at March 31, 2013

 

$

44,863